Imaging Path Revenue and Competitors
Estimated Revenue & Valuation
- Imaging Path's estimated annual revenue is currently $2.1M per year.
- Imaging Path's estimated revenue per employee is $101,500
Employee Data
- Imaging Path has 21 Employees.
Imaging Path Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.2M | 22 | 10% | N/A | N/A |
#2 | $9.1M | 70 | 0% | N/A | N/A |
#3 | $27.8M | 174 | 1% | N/A | N/A |
#4 | $1.2M | 14 | 0% | N/A | N/A |
#5 | $1M | 12 | 0% | N/A | N/A |
#6 | $1M | 11 | 10% | N/A | N/A |
#7 | $0.1M | 2 | -78% | N/A | N/A |
#8 | $0.1M | 1 | -75% | N/A | N/A |
#9 | $2.9M | 29 | -12% | N/A | N/A |
#10 | $2.3M | 23 | -8% | N/A | N/A |
What Is Imaging Path?
IMAGING PATH is a locally-owned company that provides innovative office technology to improve our clients' business processes. We have partnered with CANON, LANIER ( A Ricoh Family ) and WESTBROOK to provide you with the top products in the industry. Choosing the world's most consistent high-quality and reliable imaging systems is one thing. Finding a company to not only supply the equipment, but also support it with quality service is another. At IMAGING PATH, our unparalleled knowledge and service makes us the leading CANON and LANIER distributor in Minnesota.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$2.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Imaging Path News
... Radiology and Biomedical Imaging, University of California, San Francisco (UCSF), spoke with GU Oncology about his unusual career path.
Five years after her stage 4 metastatic breast cancer diagnosis, Kohl says she is "way beyond what they told me my life expectancy would be.
Intravascular photoacoustic imaging can provide excellent ... has great potential in intravascular imaging to pave a new path to evaluate...
Other Companies in Bloomington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.3M | 21 | 0% | N/A |
#2 | N/A | 21 | 0% | N/A |
#3 | $2.4M | 21 | 24% | N/A |
#4 | $2.1M | 21 | 5% | N/A |
#5 | $3.5M | 21 | 24% | N/A |